Oxygen Reserve Index to Reduce Hyperoxia

Hyperoxemia Clinical Trial

Official title:
Efficacy of Oxygen Reserve Index (ORI) to Reduce Hyperoxia in Major Abdominal Surgery

Status Completed

Clinical Trial Summary

Excessive oxygen administration is known to cause oxidative stress, and absorption atelectasis. Hyperoxia is very common in general anesthesia settings. Even though there are concerns in using excessive oxygen during general anesthesia, the optimal fraction of inspired oxygen (FiO2) for general anesthesia is not well studied. The oxygen reserve index (ORI) is a parameter which can evaluate partial pressure of oxygen (PaO2) rating from 0 to 1. There are growing evidences in ORI that it might be helpful to reduce hyperoxia in critically ill patients in the intensive care unit, as well as in general anesthesia. The aim of this study is to evaluate efficacy of oxygen reserve index to reduce hyperoxemia in major abdominal surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04211246
Study type	Interventional
Source	Kangbuk Samsung Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 7, 2020
Completion date	March 28, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04772183` - OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood Gase
Not yet recruiting	`NCT06102499` - Comparison of Pulse Oximetry (SpO2) With Different Oximeters and Arterial Saturation (SaO2): Oxygap2 Study
Recruiting	`NCT05912543` - A Titration of Fractional Inspired Oxygen Using Oxygen Reserve Index in Child	N/A
Recruiting	`NCT04198077` - Conservative Versus Conventional Oxygen Administration in Critically Ill Patients	Phase 4
Completed	`NCT05505032` - Oxygen Reserve Index and Prevention of Hyperoxemia	Phase 4
Completed	`NCT04965844` - Closed-loop Oxygen Control for High Flow Nasal Therapy	N/A